Study Stopped
The industry plant from which we should recruit was closed down.
Airway Inflammation Among Workers in the Silicon Carbide Processing Industry
Exposure to Aerosols and Airway Inflammation Among Workers in the Silicon Carbide Processing Industry
1 other identifier
observational
N/A
1 country
1
Brief Summary
Exposure to noxious gases and particles is associated with an increased prevalence of respiratory and cardiovascular diseases. Thus, investigation of possible airway inflammation and/or systemic inflammation in workers exposed to high levels of dust is important. Silicon Carbide (SiC) Processing Inc. provides cutting fluid (slurry) for the production of solar cells and is at present the largest provider of slurry to the solar industry worldwide. In the production process, the recyclable materials (SiC), polyethylene glycol (PEG)) of the used slurry are recovered. The airborne exposure consists mainly of SiC (dust particles) and evaporation from the recycling of PEG. High levels of dust have been measured and, seventeen per cent of the measurements in the processing hall were equal to or higher than the Norwegian occupational exposure limit. Thus, assessment of possible systemic and airway effects of this exposure is of interest. A prospective design will be applied and the effects studied by means of registration of respiratory symptoms, spirometry, nitric oxide (NO) in exhaled air, induced sputum and blood sampling over a 3 year period. Exposed subjects will also be compare with non- or low exposed subjects (administrative/office workers). Efforts will be made to include all eligible subjects and to avoid drop-outs. If early signs of airway or systemic inflammation in workers or in cells are demonstrated in the study, it will be necessary to implement measures to reduce the exposure levels. The primary aim of the present study of workers exposed to Silicon Carbide dust in the workplace is to determine whether this exposure is associated with inflammatory changes in the lungs. The secondary aims are: - to examine possible changes in systemic inflammatory markers and - to examine changes in lung function among Silicon Carbide processing workers during a period of 3 years. Possible changes in lung function will be monitored by spirometry and gas diffusion measurements (study A). Airway inflammatory responses and changes in circulating inflammatory markers will be assessed by examination of the induced sputum samples and blood samples every 6th month in a subgroup of workers (study B).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 15, 2011
CompletedFirst Posted
Study publicly available on registry
April 18, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedNovember 20, 2015
June 1, 2013
2.9 years
April 15, 2011
November 19, 2015
Conditions
Keywords
Study Arms (1)
Main study group
Inclusion criteria: Employment at one of the plants (SiC I) and (SiC II) in Porsgrunn. Both administrative/office workers and workers in the production and maintenance departments will be invited to participate. Non-smokers and smokers and male and female workers will be included in the main study group (study A). Sputum part of study: nonsmokers.
Eligibility Criteria
Employment at one of the plants (SiC I) and (SiC II) in Porsgrunn. Both administrative/office workers in the production and maintenance departments will be invited to participate. Non- smokers and smokers and male and female workers will be included in the main study group. Only non- smokers will be included in the sputum part of the study.
You may qualify if:
- Employment at SiC plant in Porsgrunn;
You may not qualify if:
- smoking
- active airway infection or less then 3 weeks after recovery
- active allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sykehuset Telemarklead
- Oslo University Hospitalcollaborator
- National Institute of Occupational Health, Norwaycollaborator
- University of North Carolinacollaborator
Study Sites (1)
Sykehuset Telemark
Skien, Telemark, 3710, Norway
Related Publications (12)
Sioutas C, Delfino RJ, Singh M. Exposure assessment for atmospheric ultrafine particles (UFPs) and implications in epidemiologic research. Environ Health Perspect. 2005 Aug;113(8):947-55. doi: 10.1289/ehp.7939.
PMID: 16079062BACKGROUNDBruch J, Rehn B, Song H, Gono E, Malkusch W. Toxicological investigations on silicon carbide. 1. Inhalation studies. Br J Ind Med. 1993 Sep;50(9):797-806. doi: 10.1136/oem.50.9.797.
PMID: 8398873BACKGROUNDBruch J, Rehn B, Song W, Gono E, Malkusch W. Toxicological investigations on silicon carbide. 2. In vitro cell tests and long term injection tests. Br J Ind Med. 1993 Sep;50(9):807-13. doi: 10.1136/oem.50.9.807.
PMID: 8398874BACKGROUNDAllen M, Butter R, Chandra L, Lettington A, Rushton N. Toxicity of particulate silicon carbide for macrophages, fibroblasts and osteoblast-like cells in vitro. Biomed Mater Eng. 1995;5(3):151-9.
PMID: 8555965BACKGROUNDFell AK, Sikkeland LI, Svendsen MV, Kongerud J. Airway inflammation in cement production workers. Occup Environ Med. 2010 Jun;67(6):395-400. doi: 10.1136/oem.2009.047852. Epub 2009 Oct 22.
PMID: 19854695BACKGROUNDToren K, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest. 1993 Aug;104(2):600-8. doi: 10.1378/chest.104.2.600.
PMID: 7802735BACKGROUNDMiller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.
PMID: 16055882BACKGROUNDMacintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005 Oct;26(4):720-35. doi: 10.1183/09031936.05.00034905. No abstract available.
PMID: 16204605BACKGROUNDSikkeland LI, Haug T, Stangeland AM, Flatberg G, Sostrand P, Halvorsen B, Kongerud J. Airway inflammation in paper mill workers. J Occup Environ Med. 2007 Oct;49(10):1135-42. doi: 10.1097/JOM.0b013e31814b2e87.
PMID: 18000418BACKGROUNDPin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992 Jan;47(1):25-9. doi: 10.1136/thx.47.1.25.
PMID: 1539140BACKGROUNDSikkeland LI, Kongerud J, Stangeland AM, Haug T, Alexis NE. Macrophage enrichment from induced sputum. Thorax. 2007 Jun;62(6):558-9. doi: 10.1136/thx.2006.073544. No abstract available.
PMID: 17536036BACKGROUNDAmerican Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005 Apr 15;171(8):912-30. doi: 10.1164/rccm.200406-710ST. No abstract available.
PMID: 15817806BACKGROUND
Biospecimen
Induced sputum, serum, citrate- plasma, EDTA-plasma, whole blood and a PaxGene sample for DNA isolation. Cell isolation, RNA isolation and gene expression analysis. Fluid phase analyses.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Johny Kongerud, professor
Oslo University; Oslo University Hospital
- PRINCIPAL INVESTIGATOR
Berit Bakke, PhD
National Institute of Occupational Health
- PRINCIPAL INVESTIGATOR
Anne Kristin M Fell, MD
Sykehuset Telemark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant
Study Record Dates
First Submitted
April 15, 2011
First Posted
April 18, 2011
Study Start
March 1, 2011
Primary Completion
February 1, 2014
Study Completion
December 1, 2014
Last Updated
November 20, 2015
Record last verified: 2013-06